Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, ...

Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis, prognosis, and therapeutic ...

Researchers have demonstrated the potential of the innovative optical genome mapping (OGM) technique for the diagnosis ...

A review paper published last year in European Journal of Medicinal Chemistry characterized Myc as the “oncogene from ...

Early infection incidence in patients with multiple myeloma following treatment with cilta-cel infusion highlights the ...

The abnormal accumulation of antibody-producing immune cells in the lungs may contribute to IPF progression, a new study ...

A new study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National ...

Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for human disease through the analysis of chromosomal ...

Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the European Commission (EC) has approved an indication extension of DARZALEX® (daratumumab) subcutaneous (SC) ...

The following is a summary of “BCMA CAR-T therapy as salvage therapy in patients with plasmablastic myeloma,” published in ...

A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients ...